ORBIMED CAPITAL LLC
SEC CIK 1157524 · EDGAR
BoughtSold
Most active insiders at SPRY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chakma Justin | Chief Business Off | — | $1.48M |
| 2 | Karas Eric | Chief Commercial Off | — | $250.0K |
| 3 | Dorsey Brian | COO | — | $190.1K |
| 4 | Fitzpatrick Alexander A | CLO | — | $33.5K |
| 5 | Shah Pratik | Dir | — | — |
ORBIMED CAPITAL LLC made no open-market trades at SPRY in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-08-28 | 2024-08-26 | SPRY | ARS Pharmaceuticals, Inc. | ORBIMED CAPITAL LLC | Dir | S - Sale | $13.00 | -83.7K | 0 | -100% | -$1.09M |
| MI | 2024-08-23 | 2024-08-21+ | SPRY | ARS Pharmaceuticals, Inc. | ORBIMED CAPITAL LLC | Dir | S - Sale | $13.24 | -868.7K | 544.7K | -61% | -$11.50M |
| I | 2023-05-24 | 2023-05-22 | PRLD | Prelude Therapeutics Inc | ORBIMED CAPITAL LLC | Dir, 10% | P - Purchase | $5.75 | +869.6K | 10.12M | +9% | +$5.00M |
| MI | 2022-04-08 | 2022-04-06+ | ARQT | Arcutis Biotherapeutics, Inc. | ORBIMED CAPITAL LLC | 10% | S - Sale | $20.68 | -878.2K | 451.1K | -66% | -$18.16M |
Purchase Sale Sale after option exercise All abbreviations